Last Friday, a new article about DEBx Medical and our product DEBRICHEM was published online on Bioworld Medtech. The article states, among other things, that we have advanced to the pre-launch phase for our new topical desiccant gel for the treatment of chronic infected and necrotic wounds. Two months after obtaining CE mark approval for DEBRICHEM, we are now starting distribution of our class IIb medical device in Europe – in the Netherlands, Italy and Spain – as well as in Hong Kong, South Africa, New Zealand and Australia.
Curious about what else the journalist had to say about our company and product?
Click here to get access to the full article.